Law360, New York (January 29, 2007, 12:00 AM ET) -- The U.S. Department of Justice has joined a whistleblower lawsuit against an Ohio-based drug company it is responsible for inflating claims to Medicare and Medicaid claims by as much as 1,000%.
Boehringer Ingelheim Roxane Inc. is accused of reporting fraudulent prices for several pharmaceutical products, knowing that federal health care programs establish reimbursement rates based on those reported prices. Medicare and Medicaid have reimbursed Roxane’s customers more than $500 million for the pharmaceutical company’s generic drugs, the DOJ said.
The DOJ, which joined the lawsuit Monday,...
DOJ: Roxane Bilked Medicare, Medicaid
To view the full article, take a free trial now.
